Aristo Bio-Tech Reports H1 FY27 Results with PAT Growth to Rs 4.90 Crore
Aristo Bio-Tech & Lifescience Ltd 路 Outcome 路 15 Nov 2026, 2:24 am
Aristo Bio-Tech Reports H1 FY27 Results with PAT Growth to Rs 4.90 Crore Aristo Bio-Tech and Lifescience Limited reported standalone revenue from operations of Rs 198.24 crore for the half-year ended 30th Sep'26, down 22.7% YoY compared to Rs 256.45 crore in the corresponding period ended 30th Sep'25. Net profit rose 17.6% YoY to Rs 4.90 crore from Rs 4.17 crore, driven by lower material costs. Profit before tax stood at Rs 6.60 crore versus Rs 5.54 crore. Basic and diluted EPS improved to Rs 7.20 from Rs 6.12 YoY. Net operating cash flow was Rs 2.42 crore.
Original exchange filing (PDF)
More announcements from Aristo Bio-Tech & Lifescience Ltd
- Aristo Bio-Tech And Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Aristo Bio-Tech and Lifescience Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 14 Nov 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Re-Appointment of Ms. Rashmi Kamlesh Otavani as Non- Executive Independent Director of the company w.e.f. March 20, 2027. 路 02 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Appointment of Mr Ketankumar Harkantbhai Modi as whole Time Director of the company w.e.f. March 20, 2027. 路 02 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 02 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026. 路 01 Oct 2026
- Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding 'Web-link of Annual Report for Financial Year 2025-26 to those Members who have not registered their e-mail addresses'. 路 11 Sept 2026
